Greenwood Capital Associates LLC Harvard Bioscience Inc Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 225,866 shares of HBIO stock, worth $483,353. This represents 0.08% of its overall portfolio holdings.

Number of Shares

225,866

Previous 206,934 9.15%

Holding current value

$483,353

Previous $589,000 3.06%

% of portfolio

0.08%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$2.64 - $3.54 $49,980 - $67,019	18,932 Added 9.15%	225,866 $607,000
Q2 2024 Aug 08, 2024	SELL	$2.77 - $4.63 $26,813 - $44,818	-9,680 Reduced 4.47%	206,934 $589,000
Q1 2024 May 01, 2024	SELL	$4.02 - $5.39 $16,035 - $21,500	-3,989 Reduced 1.81%	216,614 $918,000
Q4 2023 Mar 05, 2024	SELL	$4.0 - $5.49 $35,828 - $49,173	-8,957 Reduced 3.9%	220,603 $1.18 Million
Q3 2023 Oct 18, 2023	BUY	$4.0 - $5.82 $6,464 - $9,405	1,616 Added 0.71%	229,560 $987,000
Q2 2023 Aug 07, 2023	SELL	$4.19 - $6.16 $202,888 - $298,279	-48,422 Reduced 17.52%	227,944 $1.25 Million
Q1 2023 May 12, 2023	SELL	$2.45 - $4.22 $14,670 - $25,269	-5,988 Reduced 2.12%	276,366 $1.16 Million
Q4 2022 Jan 26, 2023	BUY	$2.12 - $2.86 $10,000 - $13,490	4,717 Added 1.7%	282,354 $0
Q3 2022 Nov 10, 2022	SELL	$2.33 - $3.92 $9,003 - $15,146	-3,864 Reduced 1.37%	277,637 $711,000
Q2 2022 Aug 10, 2022	BUY	$3.28 - $6.42 $191,952 - $375,711	58,522 Added 26.25%	281,501 $1.01 Million
Q1 2022 May 10, 2022	BUY	$5.16 - $7.14 $34,138 - $47,238	6,616 Added 3.06%	222,979 $1.39 Million
Q4 2021 Feb 03, 2022	BUY	$6.37 - $8.18 $25,161 - $32,311	3,950 Added 1.86%	216,363 $1.53 Million
Q3 2021 Oct 27, 2021	BUY	$6.98 - $8.47 $13,687 - $16,609	1,961 Added 0.93%	212,413 $1.48 Million
Q2 2021 Aug 16, 2021	SELL	$5.44 - $8.4 $968 - $1,495	-178 Reduced 0.08%	210,452 $1.75 Million
Q1 2021 May 14, 2021	BUY	$3.91 - $6.99 $11,385 - $20,354	2,912 Added 1.4%	210,630 $1.15 Million
Q4 2020 Feb 09, 2021	BUY	$3.0 - $4.5 $175,128 - $262,692	58,376 Added 39.09%	207,718 $891,000
Q3 2020 Nov 12, 2020	BUY	$2.75 - $4.2 $92,851 - $141,808	33,764 Added 29.21%	149,342 $450,000
Q2 2020 Aug 12, 2020	BUY	$2.12 - $3.14 $14,943 - $22,133	7,049 Added 6.5%	115,578 $358,000
Q1 2020 May 12, 2020	SELL	$1.42 - $3.29 $24,749 - $57,341	-17,429 Reduced 13.84%	108,529 $240,000
Q4 2019 Feb 12, 2020	BUY	$2.45 - $3.25 $68,781 - $91,240	28,074 Added 28.68%	125,958 $0
Q3 2019 Nov 12, 2019	BUY	$1.59 - $3.47 $34,892 - $76,149	21,945 Added 28.9%	97,884 $301,000
Q2 2019 Aug 13, 2019	SELL	$1.93 - $4.59 $4,377 - $10,410	-2,268 Reduced 2.9%	75,939 $152,000
Q1 2019 May 03, 2019	BUY	$2.77 - $4.38 $2,357 - $3,727	851 Added 1.1%	78,207 $337,000
Q4 2018 Feb 11, 2019	BUY	$3.03 - $5.0 $68,620 - $113,235	22,647 Added 41.4%	77,356 $246,000
Q3 2018 Nov 13, 2018	BUY	$5.0 - $6.65 $273,545 - $363,814	54,709 New	54,709 $287,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Harvard Bioscience Inc Transaction History